Ipilimumab With or Without Dabrafenib, Trametinib, and/or Nivolumab in Treating Patients With Melanoma That Is Metastatic or Cannot Be Removed by Surgery

Clinical Trial ID NCT01940809

PubWeight™ 17.51^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01940809

Top papers